BrainZell
PrivateLast Round
Grant
Dec 1, 2025
Est. Valuation
$7.57M
Total Funding Raised
$1.65M
Company Overview
BrainZell is a biotechnology company that develops stem cell-derived human brain organoid models for drug discovery and toxicity testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrainZell Comparables
Compare BrainZell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| a:head bio AG | 84% | |
| 28bio | 82% | |
| Herophilus | 81% | |
BrainZell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 1, 2025 | ||||
| Seed | Aug 27, 2024 | ||||
| Accelerator | Jun 1, 2024 |
Key People
Founding team and executive leadership
BrainZell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Life Science Invest | Seed |
| Life Science Invest | Seed |
| Norrsken Accelerator | Seed, Accelerator |
| Vinnova | Grant |
| Industrifonden | Seed |
| The Creator Fund | Seed |
BrainZell Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BrainZell's valuation, stock price, and market status.